| Financial Year |
March 31 2023 |
| Monetary Funds |
6,052,446,044.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,011,306,463.50 |
| Accounts Receivable |
1,913,874,772.04 |
| Advances to Suppliers |
1,496,714,386.29 |
| Other Receivables |
14,492,645.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
200,000.00 |
| Inventories |
12,261,721,928.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
838,134,045.63 |
| Total Current Assets |
35,311,857,822.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,613,228,575.20 |
| Investment Properties |
-- |
| Fixed Assetes |
91,466,369,474.96 |
| Under-construction Projects |
6,075,425,070.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,127,861,351.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,540,824.32 |
| Deferred Income Tax Assets |
373,852,538.45 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
107,126,387,145.48 |
| Total Assets |
142,438,244,967.73 |
| Short-Term Loans |
27,758,250,270.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,165,370,000.00 |
| Accounts Payable |
21,050,114,851.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
589,950,696.98 |
| Taxes Payable |
265,909,541.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,202,626,417.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,806,242,033.91 |
| Other Current Liabilities |
7,743,367,730.35 |
| Sub-Total of Current Liabilities |
72,934,442,715.42 |
| Long-term Loans |
11,814,950,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,300,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
510,161,518.29 |
| Other Non-Current Liabilities |
4,448,725,504.50 |
| Sub-Total of Non-Current Liabilities |
17,395,990,632.57 |
| Total Liabilities |
90,330,433,347.99 |
| Paid-In Capital(Or Share Stock) |
7,819,869,170.00 |
| Capital Surplus |
30,148,353,011.27 |
| Surplus Reserve |
1,908,883,208.67 |
| LESS:Treasury Stock |
210,930,850.00 |
| Undistributed Profits |
8,537,222,139.17 |
| Minority Stockholder's Interest |
3,644,577,029.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
48,463,234,590.45 |
| Owner's Equity（Stockholder's Equity） |
52,107,811,619.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
142,438,244,967.73 |
